Jarrow L RogovinLos Angeles, CA

7682606, Mar 23, 2010

Apr 3, 2008

12/061791

Siddharth Shastri - Los Angeles CA, US
Peilin Guo - Gardena CA, US
Jarrow L. Rogovin - Los Angeles CA, US

Jarrow Formulas, Inc. - Los Angeles CA

A01N 65/00
A61K 9/00
A61K 47/00

424 935, 424400, 424439

Methods are described for producing reduced, methylated, biologically active forms of folate, including 5-methyltetrahydrofolate (i. e. 5-methyltetrahydropteroylglutamic acid), 5-formyltetrahydrofolate, 10-formyltetrahydrofolate and tetrahydrofolate. Edible mushroom-producing fungi are cultivated to enhance the uptake of pteroylmonoglutamate (synthetic folate) into edible portions of the plants. The mushroom-producing fungi reduce and methylate the pteroylmonoglutamates into activated folates. The cultivated mycelia or mushrooms of the mushroom-producing fungi are harvested, and may be consumed directly or processed into oral dosage formats (capsules, tablets, softgels, powders, gel packets, liquids, nutritional bars, beverages) for use as functional foods or nutritional supplements.

2004025, Dec 23, 2004

Apr 9, 2004

10/821609

Siddharth Shastri - Los Angeles CA, US
Peilin Guo - Gardena CA, US
Jarrow Rogovin - Los Angeles CA, US

A61K035/84
A01G001/04
A61K031/525

424/195150, 047/001100, 514/251000

Methods are described for producing reduced, methylated, biologically active forms of folate, including 5-methyltetrahydrofolate (i.e. 5-methyltetrahydropteroylglutamic acid), 5-formyltetrahydrofolate, 10-formyltetrahydrofolate and tetrahydrofolate. Edible mushroom-producing fungi are cultivated to enhance the uptake of pteroylmonoglutamate (synthetic folate) into edible portions of the plants. The mushroom-producing fungi reduce and methylate the pteroylmonoglutamates into activated folates. The cultivated mycelia or mushrooms of the mushroom-producing fungi are harvested, and may be consumed directly or processed into oral dosage formats (capsules, tablets, softgels, powders, gel packets, liquids, nutritional bars, beverages) for use as functional foods or nutritional supplements.

2006019, Sep 7, 2006

Mar 1, 2006

11/365539

Siddharth Shastri - Los Angeles CA, US
Jarrow Rogovin - Los Angeles CA, US
Kevin Connolly - Culver City CA, US

A61K 38/43
A61K 31/12
A61K 36/534
A61K 36/752
A61K 36/23

424094100, 424725000, 424736000, 424747000, 514690000

The present invention relates to a combination of a hermetically sealed, substantially air-tight container, and a quinone-containing composition disposed therein. The container of the present invention is adapted for the convenient transport, and storage of an effective amount of an active ingredient, for example, ubiquinone, ubiquinol or a mixture thereof, and at least one pharmaceutically acceptable excipient. In another aspect the invention relates to a hermitically sealed container comprising an composition containing a single daily dose of ubiquinone, ubiquinol or both.

2006025, Nov 16, 2006

Apr 14, 2006

11/404519

Jarrow Rogovin - Los Angeles CA, US

A61K 38/43
A61K 9/48
A61K 9/20
A61K 9/14
A61K 36/53

424094100, 424451000, 424464000, 424745000, 424487000

A dietary supplement comprising Coenzyme Q10 (i.e. ubiquinone) and a bioadhesive substance is described. Derivatives of Coenzyme Q10 may also be used in the dietary supplement. The dietary supplement may be provided to an individual to increase blood plasma levels of Coenzyme Q10.

2007010, May 10, 2007

Nov 10, 2005

11/270564

Peilin Guo - Gardena CA, US
Jarrow Rogovin - Los Angeles CA, US
Ephraim Lansky - Haifa, IL

A61K 36/06
A61K 36/185

424195160, 424777000

Dietary supplements useful for treating or preventing cardiac disease are disclosed According to some embodiments, the presently disclosed supplement includes a pomegranate product fermented with a statin-producing fungus such one or more of and Alternatively or additionally, the presently disclosed supplement includes a pomegranate product in combination with a plant product, such as a grain product and a legume, fermented with the statin-producing fungus. Optionally, the supplement includes at least one of coenzymeQ10 and a tocopherol. The presently disclosed dietary supplements include both a COX-2 inhibitor and a HMG-CoA reductase inhibitor, and in some embodiments, the supplement is useful for reducing or controlling blood cholesterol for managing atherosclerotic disease, and/or for managing blood pressure. Methods of preparing the presently disclosed dietary supplement are also provided.

2014027, Sep 18, 2014

Mar 14, 2014

14/212172

- Los Angeles CA, US
Jarrow L. Rogovin - Los Angeles CA, US

JARROW FORMULAS, INC. - Los Angeles CA

A01G 1/04
A61K 36/07
A61K 36/076

42419515, 47 11

Methods are described for producing reduced, methylated, biologically active forms of folate, including 5-methyltetrahydrofolate (i.e. 5-methyltetrahydropteroylglutamic acid), 5-formyltetrahydrofolate, 10-formyltetrahydrofolate and tetrahydrofolate. Edible mushroom-producing fungi are cultivated to enhance the uptake of pteroylmonoglutamate (synthetic folate) into edible portions of the plants. The mushroom-producing fungi reduce and methylate the pteroylmonoglutamates into activated folates. The cultivated mycelia or mushrooms of the mushroom-producing fungi are harvested, and may be consumed directly or processed into oral dosage formats (capsules, tablets, softgels, powders, gel packets, liquids, nutritional bars, beverages) for use as functional foods or nutritional supplements.